Trial Outcomes & Findings for Gait Modifications and Cutaneous Stimulation (NCT NCT02884414)

NCT ID: NCT02884414

Last Updated: 2021-01-08

Results Overview

Within-subject change in peak knee flexion moment (%Bodyweight\*Height) with the intervention versus control (without the intervention).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

56 participants

Primary outcome timeframe

Immediate

Results posted on

2021-01-08

Participant Flow

Participant milestones

Participant milestones
Measure
Cutaneous Stimulation
Cutaneous stimulation and/or feedback. This stimulation and/or feedback may be visual, auditory, tactile (e.g. vibratory, temperature), or haptic and is completely external. Cutaneous stimulation: A non-invasive external device that will be placed on the leg of the subject. The device consists of a sensing module to determine specific points in the gait cycle, a processor to analyze signal from the sensor, and a stimulus module to provide feedback to the subject.
Overall Study
STARTED
56
Overall Study
COMPLETED
56
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Data excluded from n=3 participants due to technical data collection issue.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Cutaneous Stimulation
n=56 Participants
Cutaneous stimulation and/or feedback. This stimulation and/or feedback may be visual, auditory, tactile (e.g. vibratory, temperature), or haptic and is completely external. Cutaneous stimulation: A non-invasive external device that will be placed on the leg of the subject. The device consists of a sensing module to determine specific points in the gait cycle, a processor to analyze signal from the sensor, and a stimulus module to provide feedback to the subject.
Age, Continuous
47.8 years
STANDARD_DEVIATION 18.5 • n=56 Participants
Sex: Female, Male
Female
26 Participants
n=56 Participants
Sex: Female, Male
Male
30 Participants
n=56 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=56 Participants
Race (NIH/OMB)
Asian
17 Participants
n=56 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=56 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=56 Participants
Race (NIH/OMB)
White
36 Participants
n=56 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=56 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=56 Participants
Region of Enrollment
United States
56 participants
n=56 Participants
Knee Flexion Moment
2.68 %Bw*Ht
STANDARD_DEVIATION 1.29 • n=53 Participants • Data excluded from n=3 participants due to technical data collection issue.

PRIMARY outcome

Timeframe: Immediate

Within-subject change in peak knee flexion moment (%Bodyweight\*Height) with the intervention versus control (without the intervention).

Outcome measures

Outcome measures
Measure
Cutaneous Stimulation
n=53 Participants
Cutaneous stimulation and/or feedback. This stimulation and/or feedback may be visual, auditory, tactile (e.g. vibratory, temperature), or haptic and is completely external. Cutaneous stimulation: A non-invasive external device that will be placed on the leg of the subject. The device consists of a sensing module to determine specific points in the gait cycle, a processor to analyze signal from the sensor, and a stimulus module to provide feedback to the subject.
Change in Peak Knee Flexion Moment (%Bw*Ht)
2.72 %Bw*Ht
Standard Deviation 1.25

Adverse Events

Cutaneous Stimulation

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jennifer Hledik

Stanford University

Phone: 650-493-5000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place